RESOURCE CENTER
Latest Publications
Hard-earned Insights That Help Drug Manufacturers Achieve Their Growth, Compliance, & Profitability Objectives
PHS/340B Audit Survival Guide
PHS/340B Audit Survival GuideEven the most disciplined and compliant companies dread receiving a letter or an email informing them of an impending audit. Nobody likes being put under the microscope. It doesn’t take a great deal of imagination to know what it feels...
Key Factors for Acquiring & Launching Marketed Pharmaceuticals
Factors to Consider When Acquiring and Launching A Previously Marketed PharmaceuticalContemplating Acquiring An Existing Product?Be Sure to Do Your Homework!Any pharmaceutical manufacturer who has launched a new prescription drug understands the enormity of such an...
American Rescue Plan Act of 2021
American Rescue Plan Act of 2021: Medicaid Rebate Inflation Penalties Will Soon Know No BoundsOn March 11, 2021, President Joe Biden signed into law the American Rescue Plan Act of 2021 (ARP21), also known as the COVID-19 Relief Bill. Many pharmaceutical manufacturers...
3 Key Challenges in Pharma VA/FSS Contracting
Three things to know about the challenges of VA/FSS contracting.The Veterans/Federal Supply Schedule (VA/FSS) is likely the most complex and time-consuming government contracting process you will face. Public Law 102-585 requires brand manufacturers to participate in...
Update: Drug Price Disclosure Legislation – Feb 2021
Another Update on Drug Price Disclosure LegislationMore tips for staying compliant with an accelerating trendStates Continue Their March Toward Prescription Drug Transparency Regulations. This paper, our fourth in a series that looks at the rising number of price...
Mergers and Acquisitions Never End In a Tie
Mergers and Acquisitions Never End In A Tie!When it comes to corporate mergers, the acquiring company is almost always the sole beneficiary. The people in the acquired company are, unfortunately, viewed as excess baggage. This displacement of human resources typically...
Challenges with System Based Government Pricing Solutions
Have you been lulled into complacency by a system-based government pricing solution?The idea of using a comprehensive, system-based solution for government pricing computations can be appealing. Any tool that promises compliance with complex reporting requirements for...
Baseline AMP: Guide to Compliance & Maximizing Profitability
Understanding Baseline AMP Rules Can Help You Avoid Pricing Decision DisastersWhat brand and generic drug manufacturers need to knowA lack of understanding respective to baseline Average Manufacturer Price (AMP) and how it can affect your Medicaid pricing can result...
Implementing a Generic Pharma Commercialization Plan
Understanding the complexities of implementing a generic pharmaceutical company commercialization plan.Seasoned pharma executives know that implementing a generic pharmaceutical company commercialization plan in the US market is a complex exercise in multi-tasking....